Persist AI

About:

Persist AI is a biotechnology company that builds long-acting microsphere formulations.

Website: https://www.persist-ai.com

Top Investors: Y Combinator, Pioneer Fund, Innospark Ventures, Fellows Fund, 2048 Ventures

Description:

Persist assist pharmaceutical companies in developing long-acting formulations 50% faster. Because the formulation development process is manual and relies on scientific intuition, it takes a pharmaceutical company 5-10 years to develop a long acting formulation for a drug. This effort is divided into five years of pre-clinical development and five years of clinical testing. Their goal is to use machine learning and automation to reduce the time required for pre-clinical formulation development to three months, making the formulation development process 50% faster.